• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Local Updates on COVID-19 Prevention and Treatment

Local Updates on COVID-19 Prevention and Treatment

30 May 2022/0 Comments/in COVID-19, SARS-CoV2, AIDS, Infectious Disease, HIV, Oncology, Vaccines/by Christy Leung

Coronavirus Disease 2019 (COVID-19) emerged in late 2019 and later transformed into a pandemic. Since the United States Food and Drug Administration (FDA) granted Emergency Use Authorisation for COVID-19 vaccines.

Read more
https://medi-paper.com/wp-content/uploads/2022/05/Local-Updates-on-COVID-19-Prevention-and-Treatment-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 04:49:162022-05-31 11:25:18Local Updates on COVID-19 Prevention and Treatment
Tolerability of COVID-19 vaccines in patients with cancer

Tolerability of COVID-19 vaccines in patients with cancer

17 May 2022/0 Comments/in COVID-19, SARS-CoV2, Infectious Disease, Oncology/by Christy Leung

SARS-CoV-2 virus is the causative agent of Coronavirus Disease 2019 (COVID-19) and has infected many over the past two-and-a-half years, including healthy people and those with underlying co-morbidities such as the immunocompromised. Following the administration of COVID-19 vaccines from late 2020 onwards, severe and critical COVID-19 outcomes decreased by over 60%.

Read more
https://medi-paper.com/wp-content/uploads/2022/05/Tolerability-of-COVID-19-vaccines-in-patients-with-cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-17 02:20:592022-05-17 05:46:03Tolerability of COVID-19 vaccines in patients with cancer
US and Chinese Studies Suggest More Severe Outcomes in COVID-19 Patients with Cancer

More Severe Outcomes in COVID-19 Patients with Cancer

16 May 2022/0 Comments/in COVID-19, Breast Cancer, Haematology, Infectious Disease, Lung Cancer, Oncology, Chemotherapy, Immunotherapy/by Christy Leung

Severe COVID-19 infection does not only bring about patient distress, but also increases public health expenditure in supportive devices such as ventilators. It is necessary to minimise the risk of COVID-19 infection in cancer patients, considering COVID-19 waves are likely to recur regularly and they are the high-risk groups. Personal hygiene measures and COVID-19 vaccination have been demonstrated to be efficacious and should be recommended to cancer patients for lowering the likelihood of hospitalisation, ICU admission and mortality.

Read more
https://medi-paper.com/wp-content/uploads/2022/05/US-and-Chinese-Studies-Suggest-More-Severe-Outcomes-in-COVID-19-Patients-with-Cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-16 08:12:092022-05-17 05:46:03More Severe Outcomes in COVID-19 Patients with Cancer
COVID-19 vaccination safety and effectiveness for pregnant and lactating women

COVID-19 vaccination safety and effectiveness for pregnant and lactating women

3 May 2022/Enter your password to view comments./in COVID-19, Infectious Disease, Vaccines/by Connie TANG

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-03 02:34:242022-05-17 05:46:03COVID-19 vaccination safety and effectiveness for pregnant and lactating women
Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

29 April 2022/0 Comments/in COVID-19, SARS-CoV2, Pneumonia, Infectious Disease/by Christy Leung

The gut microbiome is known to interact with infection and immunity, such as immune response after BCG vaccine and COVID-19 disease prognosis. Investigators are thus interested to learn whether certain gut microbiome composition can be prognostic indicators for adverse event occurrence and vaccine efficacy.

Read more
https://medi-paper.com/wp-content/uploads/2022/04/Gut-Microbiome-Predictor-for-COVID-19-Vaccine-Response-and-Safety-CZ02-and-BNT162b2-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 10:30:502022-05-17 05:46:03Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)
US Study Suggests A Lesser-known COVID-19 Complication Diabetes Mellitus

US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus

29 April 2022/0 Comments/in COVID-19, Infectious Disease/by Christy Leung
Read more
https://medi-paper.com/wp-content/uploads/2022/04/US-Study-Suggests-A-Lesser-known-COVID-19-Complication-Diabetes-Mellitus-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 05:47:272022-05-17 05:46:03US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus
Vaccination Strategies and Management Against Omicron Outbreak

Vaccination Strategies and Management Against Omicron Outbreak

1 April 2022/Enter your password to view comments./in COVID-19, Infectious Disease, Vaccines/by Connie TANG

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/03/Vaccination-Strategies-and-Management-Against-Omicron-Outbreak.png 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-04-01 03:37:202022-05-17 05:46:03Vaccination Strategies and Management Against Omicron Outbreak
UK study_Infected adolescents are at higher risk of long COVID symptoms

UK study: Infected adolescents are at higher risk of long COVID symptoms

1 March 2022/0 Comments/in COVID-19, Infectious Disease/by Connie TANG
Read more
https://medi-paper.com/wp-content/uploads/2022/03/UK-study_Infected-adolescents-are-at-higher-risk-of-long-COVID-symptoms.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-03-01 07:20:182022-05-17 05:46:03UK study: Infected adolescents are at higher risk of long COVID symptoms
Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

28 February 2022/0 Comments/in COVID-19, Infectious Disease/by Chloe FUNG
Read more
https://medi-paper.com/wp-content/uploads/2022/02/Antiviral-Molnupiravir-Associated-with-Reduced-Risk-of-Hospitalisation-or-Death-in-COVID-19-Patients.jpg 1024 1918 Chloe FUNG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Chloe FUNG2022-02-28 07:41:092022-05-17 05:46:03Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

20 December 2021/in COVID-19, Infectious Disease/by Connie TANG

The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that have an increasing incidence and prevalence in different regions around the world.

Read more
https://medi-paper.com/wp-content/uploads/2021/12/Anti-TNF-Therapy-Correlated-with-Better-Outcomes-in-IBD-Patients-with-COVID-19.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-20 12:58:472022-05-17 05:46:03Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19
Page 3 of 6‹12345›»

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only